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CHOLERA - THE NEW EPIDEMIC?
The article by Athan et a/I in this issue of the SAMJ is an
admirable example of what can be achieved if a health
department is adequately prepared for an outbreak of any
infectious disease. Timely staff training, education of the local
population and vigilance on the part of local health authorities
undou~tedlycontributed to the containment of an outbreak of
cholera due to Vibrio cho/erae 01 El Tor Ogawa that could
otherwise have reached epidemic proportions. Unfortunately it
is too soon to celebrate, and there can be no room for
complacency. The Mozambican cholera epidemic is ongoing,
and although the situation may have quietened with the onset
of winter, as summer approaches and the rivers start to flow
again we can expect the epidemic to resurge in Mozambique
and possibly reappear in the South African population at risk.
Vigilance and pro-active measures will be required once more
to contain the South African cases and limit them to
Mpumalanga, with the occasional case imported to Gauteng or
elsewhere.
During the last outbreak of cholera in this country in the
early 1980s, 25 251 laboratory-confirmed cases were reported
between 1980 and 1986. This epidemic was caused by V
cha/erne 01 El Tor Inaba,' and took 7 years finally to disappear.
There were 348 deaths.' An 'acceptable case fatality rate' of less
than 1% can be achieved by improved treatment, particularly
oral rehydration therapy.'
Rehydration therapy is the single most critical treatment
modality in cholera. Cholera toxin is an AB; heterohexamer.
The B subunits bind to the GM, ganglioside on the brush
border of the small-intestine epithelium. The A subunit then
causes ADP-ribosylation of adenylate cyclase, resulting in
elevated cAMP and active emux of electrolytes, the osmotic
pressure causing large quantities of water, sometimes litres a
day, to be lost through the gastro-intestinal tract.'
It is now recognised that in approximately 90% of cases
cholera is mild and may be indistinguishable from other acute
diarrhoeal diseases.' In this group of patients oral rehydration
should be adequate. In patients with severe diarrhoea,
particularly those in hypovolaemic shock, intravenous
rehydration with Ringer's lactate is required.' These patients
should be placed on oral rehydration solution as soon as they
can drink, eveh if further intravenous rehydration is necessary.
The use of antibiotics in the treatment of cholera is
controversial. Although it has been shown that they shorten the
course of the disease/'· once dehydration is corrected the
patient normally recovers fully, even when not given
antibiotics. The World Health Organisation recommends
optional oral antibiotics including doxycycline for adults or
furazolidone (not available in South Africa), trimethoprim-
sulfamethoxazole, or erythromycin for children, or as
alternatives to doxycycline in adults.' The strain currently
involved in cases in South Africa is resistant to all of these in
the laboratory, although resistance to erythromycin does not
necessarily reflect the in vivo situation. Antimicrobial resistance
of V. cho/erne to multiple antibiotics is a worldwide trend.7•n
Multiple antibiotic resistance in V cho/erae 01 has been shown
to be mediated by a plasmid9-n which is easily transferable
between V cho/erae and other Gram-negative strains. l1 This
implies that under selective antibiotic pressure, even in the
absence of a cholera epidemic, a reservoir of antibiotic
resistance genes ready for transfer to V cho/erne can be
maintained among indigenous intestinal bacteria.
Antibiotic resistance is thought to have originated from
extensive use of tetracycline prophylaxis and treatment in
cholera epidemics.7.' As plasmids frequently encode resistance
to more than one antibiotic, the use of a single antibiotic may
select for resistance to others."!· large-scale antibiotic
prophylaxis and treatment in cholera is therefore strongly
discouraged for a number of reasons: (i) it may select for
plasmid-mediated antibiotic resistance; (ii) most cases are not
severe and can be controlled with oral rehydration therapy;
and (iii) large-scale antibiotic prophylaxis, like large-scale
vaccination, has never been shown to be effective in preventing
a cholera outbreak.3
Recently in vitro and in vivo studies have shown that
fluoToquinolones are effective in the treatment of cholera.':!.l3
Moreover, single-dose therapy with a fluoroquinolone cleared
V. cho/erae 01 and V. cho/erae 0139 from the stool more rapidly
than single-dose doxycycline." Although quinolone resistance
is primarily chromosomal, and therefore should not be affected
by plasmid-mediated resistance to other antibiotics, a recent
report described plasmid-mediated quinolone resistance,
associated with resistance to multiple antibiotics as well as
antiseptics." The introduction of fluoroquinolones for the
treatment of cholera should therefore be viewed with caution
even though they appear (apart from cost considerations) to be
the logical choice for treatment of cholera caused by the drug-
resistant strain prevalent in southern Africa.
There are a number of reasons why we should expect cholera
to re-emerge this summer. Although the departments of health
in Mpumalanga and Gauteng, the two provinces affected by
the most recent outbreak, have shown themselves admirably
prepared for the disease, conditions supporting the
continuation of the epidemic remain unchanged. Large areas of
Mpumalanga still have an inadequate piped water supply and
poor sewage disposal, and the local population must rely on
faecally polluted rivers for water. Migrant labour from
Mozambique has become a fact of life in South Africa, as this
country is viewed as a source of wealth for its poorer
neighbours. These migrant workers pass through Mpumalanga
as they head towards Gauteng, or try to find work on the farms
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in Mpumalanga and settle there. Cholera, moreover, is largely a
disease of poverty, and the current economic crisis in the
country will inevitably result in more people living under
conditions of poor hygiene, which expose them to this scourge.
V. cholerae is well adapted to living in chemically polluted
water, and our rivers are notoriously polluted. l ; Furthermore,
iron contamination of water through rusty pipes and other
iron-containing structures promotes the survival and
multiplication of the organism and stimulates toxin
production.15-17 Storage of drinking water in iron containers has
been shown to be a potential risk factor for the transmission of
cholera. l •
So what can we do? Those of us in the private sector and the
State health departments should maintain vigilance and have a
high index of suspicion in situations where we know the
patient is at risk for contracting the disease. Ongoing education
of health professionals in areas at risk is mandatory, and the
provincial health departments need to remain prepared.
Creating awareness in 'at risk' populations and teaching them
basic hygiene and infection control will assist in limiting an
outbreak. The Department of Health has prepared a document
on the management of a cholera outbreak or epidemic, and
these guidelines should be followed to protect the population
as a whole. In suspected cases, especially in adults and not
necessarily only those with severe diarrhoea, stools should be
sent for culture of V. cholerae 01. Close liaison between
laboratories and health authorities should be established, and
V. cholerae isolation should immediately be reported to the local
health authority, which in turn should introduce urgent
containment procedures based on focused investigative
information relating to the rapid identification of new cases,
the likely water source and modes of transmission. Finally, we
need to realise that we are not living in isolation, and as human
traffic increases across our borders and within them, we will
continue to be exposed to emerging and re-emerging infectious
diseases, including those we believed would never affect us
again. It is critical that all members of the health community
co-operate in combating disease and that they assist the
population to do the same.
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